Expansion of the genetic code with nonstandard amino acids (nsAAs) has enabled biosynthesis of proteins with diverse new chemistries. However, this technology has been largely restricted to proteins containing a single or few nsAA instances. Here we describe an in vivo evolution approach in a genomically recoded Escherichia coli strain for the selection of orthogonal translation systems capable of multi-site nsAA incorporation. We evolved chromosomal aminoacyl-tRNA synthetases (aaRSs) with up to 25-fold increased protein production for p-acetyl-l-phenylalanine and p-azido-l-phenylalanine (pAzF). We also evolved aaRSs with tunable specificities for 14 nsAAs, including an enzyme that efficiently charges pAzF while excluding 237 other nsAAs. These variants enabled production of elastin-like-polypeptides with 30 nsAA residues at high yields (~50 mg/L) and high accuracy of incorporation (>95%). This approach to aaRS evolution should accelerate and expand our ability to produce functionalized proteins and sequence-defined polymers with diverse chemistries.
A r t i c l e s
Expansion of the genetic code by incorporation of nsAAs into proteins has enabled template-based incorporation of >100 nsAAs containing diverse chemical groups, including post-translational modifications, photocaged amino acids, bioorthogonal reactive groups, and spectroscopic labels [1] [2] [3] [4] [5] . For example, site-specific incorporation of nsAAs at a single position has been used to engineer protein-drug conjugates 6 , cross-linking proteins 7 , and enzymes with altered or improved function 8, 9 . Incorporation of nsAAs at multiple sites could further extend the function and properties of proteins and biomaterials by allowing synthesis of polypeptide polymers with programmable combinations of natural and nonstandard amino acids. However, multi-site nsAA incorporation has so far been limited by inefficiencies associated with the translation machinery and the cellular hosts in which the recombinant proteins are produced 10 .
There are two common strategies for expressing recombinant proteins containing nsAAs. The first substitutes a close synthetic analog for a natural amino acid in an auxotrophic strain 3 . This approach has been used to tag, identify, and study newly synthesized proteomes in a variety of cell types 11, 12 , to produce nsAA-containing biopolymers with improved stability 13 and with conductive chemical groups 14 , and to facilitate characterization of structural proteins 15 . However, the nsAA must be a close analog of the natural amino acid it replaces 16 , and the eliminated amino acid is excluded in the recombinant protein 3 and in the entire proteome, causing growth defects that can reduce protein yields. Alternatively, nsAAs can be incorporated by codon reassignment or frameshift codons using orthogonal translation systems consisting of an aaRS capable of charging only a cognate tRNA that is not aminoacylated by endogenous aaRSs 2, 4 . Typically, a UAG stop codon is assigned to the nsAA, and the orthogonal tRNA anticodon is mutated to CUA. Pairs of aaRSs and tRNAs from organisms such as Methanocaldococcus jannaschii and Methanosarcina species have been used to incorporate a wide variety of nsAAs 4, 17 into proteins in bacterial hosts 4, 18, 19 , but at only one or a few instances within a polypeptide chain 5, 10 .
The first challenge for multi-site nsAA incorporation using codon reassignment is to overcome competition between the orthogonal nsAA-tRNA CUA and essential translation machinery (e.g., release factor 1, RF1) for the UAG codon, which reduces full-length protein production and limits the number of nsAAs that can be incorporated into a single protein [20] [21] [22] [23] . To address this, we recently recoded all instances of the UAG codon to the synonymous UAA codon in E. coli 21, 24 . This genomically recoded organism permitted the deletion of RF1 and, therefore, elimination of translational termination at UAG codons. In this organism, UAG was changed from a stop to a sense codon, provided the appropriate translation machinery was present 21, 24 . Nevertheless, a second challenge to multi-site nsAA incorporation by codon reassignment is that the evolved aaRSs show ~100-to 1,000-fold reduced activity 5, 19 compared with native enzymes, resulting in inefficient nsAA acylation 19, 25, 26 , low levels of nsAA-tRNA and low protein yields 21, 27, 28 , particularly with multi-site nsAA incorporation 20 . We hypothesize that current approaches rely on multi-copy plasmids for aaRS and tRNA overexpression to overcome evolution of translation machinery in recoded bacteria enables multi-site incorporation of nonstandard amino acids enzyme inefficiency, which masks differences between modestly and highly active aaRSs capable of multi-site nsAA incorporation.
In this study, we describe an in vivo protein evolution approach to isolate more efficient aaRS variants for multi-site incorporation of diverse nsAAs. Specifically, we used multiplex automated genome engineering (MAGE) 29, 30 to generate libraries of chromosomally integrated aaRSs in a genomically recoded organism containing both positive-and negative-selection markers. Using this approach, we demonstrate the ability to isolate aaRS variants with increased efficiency and tunable nsAA specificities for a variety of nsAAs. We tested the selected variants on elastin-like polypeptide (ELP) fusion proteins that contain up to 30 UAG codons. ELPs are a family of unstructured protein-polymers composed of a VPGXG repeat, where X, the guest residue position, is permissive for any amino acid except proline 31 and is therefore also permissive to nsAAs. We demonstrate incorporation of 30 nsAAs per protein with high yields (~50 mg/L) and >95% fidelity of nsAA incorporation at each UAG codon.
RESULTS

Genome-wide recoding improves multi-site nsAA incorporation
We first characterized the ability of a known orthogonal translation system 32 to incorporate 3-30 nsAAs per protein in the genomically recoded organism. We previously demonstrated reduced natural suppression and elimination of protein truncation in this strain (at three UAGs) 21 . In this study, we constructed three fluorescent protein standards (Fig. 1a) : a superfolder GFP 33 containing three UAG codons at positions 39, 151 and 182 (GFP(3UAG)), and two ELP-GFP fusion proteins where the ELP contains 10 (ELP(10UAG)-GFP) or 30 (ELP(30UAG)-GFP) UAG codons at the guest residue positions. ELPs were fused to the N terminus of superfolder GFP, and control (wild-type, WT) proteins with tyrosine codons substituted for UAGs were similarly constructed ( Supplementary Notes 1 and 2) .
The genomically recoded organism 21 was co-transformed with the reporter gene and an orthogonal translation system plasmid 32 containing an aaRS:tRNA pair previously engineered for incorporation of p-acetyl-l-phenylalanine (pAcF), that is also able to incorporate p-azido-l-phenylalanine 17 (pAzF). All fusion proteins resulted in quantifiable signals. GFP fluorescence assays indicated that multi-site pAcF incorporation in the recoded strain produced 110%, 87% and 25% of pAcF containing GFP(3UAG), ELP(10UAG)-GFP and ELP(30UAG)-GFP fluorescence, respectively, and 75%, 32% and 6% of pAzF containing GFP(3UAG), ELP(10UAG)-GFP and ELP(30UAG)-GFP compared to WT proteins (Fig. 1b) . Similarly, the yield of purified ELP(30UAG)-GFP containing pAcF expressed in small batch cultures was 18% and 8% compared to expression of WT protein in the genomically recoded organism or parent (nonrecoded) strain, respectively ( Table 1) . The yield of pAzF containing ELP(30UAG)-GFP in the genomically recoded organism was too low to allow for purification. Although the genomically recoded organism improved yields of proteins containing multiple nsAAs, we hypothesized that yield would be enhanced by further evolution of the orthogonal translation systems.
Chromosomal integration highlights aaRS enzyme inefficiency
We constructed a genomically recoded organism strain containing a chromosomally integrated orthogonal translation system to enable MAGE-based evolution of the aaRS and to characterize its performance in this context. A DNA cassette based on the pAcF orthogonal translation system plasmid 32 consisting of an inducible M. jannaschii-based pAcF aaRS (pAcFRS), a constitutive tRNA CUA and a tolC selection marker ( Supplementary Fig. 1) ) was assembled and integrated in a known intergenic region (Supplementary Note 1) in the genomically recoded organism using λ Red recombination 34 . Subsequently, UAG codons were inserted by MAGE in four permissive sites in the tolC cassette, to enable negative selection (Supplementary Note 1) .
We then characterized the effect of varying aaRS (i.e., pAcFRS) and tRNA CUA concentration on GFP(3UAG) production in the genomically recoded organism. The reduction in copy number caused by genomic integration of the orthogonal translation system resulted in a ~20-fold decrease in the yield of GFP(3UAG) in the RF1-deficient genomically recoded organism, highlighting the impaired efficiency of this orthogonal translation system (Fig. 1c) . Individually increasing either pAcFRS or tRNA CUA concentration by supplementation with plasmids resulted in partial restoration of GFP(3UAG) expression (Fig. 1c) , suggesting impaired binding of pAcFRS to pAcF and to its cognate tRNA CUA , likely because the M. jannaschii TyrRS (MjTyrRS) natively recognizes the GUA anticodon 32 . These results suggest that 
npg
A r t i c l e s elevated levels of pAcFRS and tRNA CUA expression compensate for their reduced enzymatic activity.
Evolution of orthogonal translation systems in vivo
In prior work, we used MAGE to generate a genomic library of ribosome binding site sequences in which genetic diversity can be increased simply by increasing the number of MAGE cycles 29 . Here we sought to evolve protein function with a chromosomal orthogonal translation system in a genomically recoded organism by successive rounds of diversification with MAGE and negative and positive selection bypassing conventional intermediate plasmid extraction and transformation steps (Fig. 2) . To generate an aaRS library, we designed a pool of synthetic single-stranded DNA (ssDNA) oligonucleotides to mutagenize the selected amino acid targets, and used several rounds of MAGE to create a diverse library. The resulting cell population was then subjected to a tolC-based negative-selection step 35 wherein mutated aaRS variants capable of mischarging tRNA CUA with natural amino acids permitted read-through of a tolC construct containing four UAG sites, rendering the organism sensitive to colicin E1 (Supplementary Fig. 2) . Thus, the negative-selection marker is dormant unless colicin E1 is present, eliminating the need to replace or modify the cellular host for positive or negative selection. The remaining orthogonal library was subsequently screened for improved GFP(3UAG) production in the presence of either pAcF or pAzF. aaRS variants with improved performance were isolated by two rounds of fluorescence-activated cell sorting (FACS). Finally, biochemical and proteomic analyses were performed and the resulting isolated variants were evaluated for their ability to produce proteins containing up to 30 instances of pAcF or pAzF, as well as 236 other nsAAs (Supplementary Note 3) . This workflow was designed for streamlined selection from diversified populations or further diversification of selected mutants to improve or tune the properties (e.g., activity, specificity) of selected aaRSs for a variety of nsAAs (Fig. 2) .
Evolution of chromosomally integrated aaRSs variants
We used a reported crystal structure for the MjTyrRS 36 to inform the diversification of 12 residues in the amino acid binding pocket surrounding the variable side chain of the nsAA (compared with typically six or fewer residues 18, 37, 38 , with few exceptions targeting nine residues 39 ), and five residues at the aaRS-tRNA CUA anticodon recognition interface (Fig. 3a) . Synthetic degenerate ssDNA oligonucleotides were designed to randomize the residues in the nsAA binding pocket and aaRS-tRNA CUA binding interface separately (Supplementary Table 1 ) to distinguish between improved nsAA binding and tRNA CUA recognition. We screened the diversified populations of variants after five and nine MAGE cycles ( Supplementary Fig. 3 and Supplementary Note 4) by induction of GFP(3UAG) in the presence of pAcF or pAzF and performed two rounds of FACS to isolate cells with improved aaRS activity ( Supplementary Fig. 4) . The nsAA binding library produced variants with improved pAcFRS and pAzFRS incorporation efficiency ( Fig. 3a and Supplementary Table 2 ). Individual colonies selected after FACS were sequenced revealed an aaRS variant for improved pAcF incorporation (pAcFRS.1: A167D mutation) capable of about an eightfold higher GFP(3UAG) production compared with the progenitor enzyme, pAcFRS 32 (Fig. 3b) . In addition, individual colony analysis of sorted populations revealed two top variants for pAzF incorporation (pAzFRS.1: (G158V, C159M, R162D, A167Y) and pAzFRS.2: (E107T, F108Y, Q109M) mutations) capable of producing ~3.5-and ~12-fold more GFP(3UAG) than the progenitor enzyme (Fig. 3c) .
Similarly, screening of the library for aaRS-tRNA CUA binding optimization (screened for enhanced GFP(3UAG) production with pAcF) revealed two mutants, pAcFRS.t1 and pAcFRS.t2 ((R257G) or (R257C, F261E) mutations, respectively), both exhibiting ~1.5 fold 61.4 ± 10.1 pAzF GRO a Expression too low to allow sufficient purification for A280 measurement, therefore protein quantity was estimated based on fluorescence of semi-purified protein extracts. b WT ELP(30Tyrosine)-GFP proteins contain no UAGs and were expressed using E. coli native translation machinery. However, expression of ELP(30Tyrosine)-GFP was measured in the presence of pAcF or pAzF to assess for potential toxic effects of these nsAAs on protein expression. c N.D.: expression too low to allow purification of reporter protein by inverse transition cycling. Data are reported as mean ± s.d. calculated from purification of n = 3 independently grown and purified cultures. d P < 0.05 compared with pAcFRS progenitor with pAcF.
OTS, orthogonal translation system; GRO, genomically recoded organism.
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Genomically recoded E. coli (GRO) Figure 2 Evolution of chromosomally integrated aaRS variants. The genomically recoded organism (GRO) is engineered to contain a single chromosomal copy of the aaRS for diversification using MAGE, a negative-selection marker for removal of nonorthogonal translation systems (OTS) (capable of incorporation of natural amino acids), and a GFP marker for fluorescence-based identification and isolation of improved variants. Site-directed mutagenesis of chromosomally integrated translation components by MAGE generates a highly diversified population, which is subsequently subjected to tolC-and colicin E1-mediated negative selection in the absence of nsAAs. UAG suppression in GFP(3UAG) enables FACS of orthogonal aaRS libraries in the presence of the desired nsAA to identify improved variants. The selected aaRS variants are evaluated for multi-site nsAA incorporation, in vitro activity and protein purity. npg higher GFP(3UAG) production compared to the progenitor enzyme (Fig. 3b) . We then combined mutations isolated for nsAA binding and tRNA binding via MAGE, which produced four variants. These chromosomally integrated variants harboring mutations for improved pAcF or pAzF and tRNA CUA binding resulted in a synergistic ~17-fold (pAcFRS.1.t1), ~15-fold (pAcFRS.1.t2), ~5.5-fold (pAzFRS.1.t1) and ~25-fold (pAzFRS.2.t1) increase in GFP(3UAG) production compared with the progenitor enzyme (Fig. 3b,c) . Correct incorporation of pAcF or pAzF into all three sites in GFP(3UAG) was confirmed by mass spectrometry (MS; Supplementary Table 3) .
Evolution of aaRS variants with tunable nsAA specificities As several previously described aaRS variants incorporate numerous nsAAs 17, 40 (termed polyspecificity 17 ), we first determined the polyspecificity of each of our chromosomally integrated aaRS variants by assaying GFP(3UAG) production in the presence of pAcF or pAzF (Fig. 3d) as well as in the presence of 236 other nsAAs 41 . These assays revealed polyspecificity in each of our variants with the exception of pAzFRS.1 and pAzFRS.1.t1, which were exceptionally specific to pAzF ( Fig. 3e and Supplementary Fig. 5b-m) .
Based on previous studies of polyspecificity 17, 40 , we hypothesized that a customized diversification-selection experiment designed to alter the nsAA binding pocket to reject a specific nsAA would create a pocket capable of accepting new, previously excluded, nsAAs. Therefore, an additional round of evolution was performed to increase the specificity of pAcFRS.1 toward pAcF while excluding pAzF. pAc-FRS.1 was subjected to five additional MAGE cycles with an oligonucleotide pool designed to preserve the (A167D) mutation, responsible for improved activity of pAcFRS.1, and randomize the remaining 11 sites in the nsAA binding pocket. This library was subjected to tolC negative selection in the presence of pAzF, and the remaining orthogonal library was screened for improved GFP(3UAG) in the presence of pAcF by FACS. Individual colony sequencing revealed that the sorted population was enriched in an aaRS mutant (pAcFRS.2 (L65V, A167D) mutations). Comparison of GFP(3UAG) expression in the presence of pAcF or pAzF confirmed an increase in selectivity for pAcFRS.2 and pAcFRS.2.t1 toward pAcF over pAzF (Fig. 3d ,e marked by black arrow). Upon polyspecificity analysis of chromosomally integrated progenitor (pAcFRS), first-generation (pAcFRS.1.t1) and second-generation (pAcFRS.2.t1) aaRSs, we found that altering the binding pocket to exclude pAzF resulted in the selection of a variant that efficiently incorporates nsAAs (i.e., compounds 11, 12 and 14; Fig. 3e ) not incorporated by other variants. Furthermore, each of the 14 different nsAAs could be incorporated at high efficiency by selecting the appropriate aaRS variant, informed by the aaRS-nsAA specificity heat map (Fig. 3e) .
Efficient multi-site nsAA incorporation by evolved aaRSs To evaluate whether the evolved aaRSs can improve multi-site nsAA incorporation, we co-transformed the genomically recoded organism with a plasmid carrying the reporter protein with three, ten or 30 UAGs, or WT equivalents and episomal versions of each orthogonal translation system variant (Supplementary Fig. 6 ). Plate-based fluorescence analysis indicated increased incorporation of either pAcF or pAzF by our evolved orthogonal translation systems for expression of GFP(3UAG) up to 1.1-fold (pAcF) or twofold (pAzF), ELP(10UAG)-GFP up to 1.1-fold (pAcF) or 3.2-fold (pAzF), and ELP(30UAG)-GFP up to 4-fold (pAcF) or 7-fold (pAzF) (Fig. 4a- Fig. 7) . Purification of ELP(30UAG)-GFP containing pAcF expressed by the genomically recoded organism in small-batch cultures revealed a fivefold increase in protein production of up to 54 mg/L (i.e., >90% of WT-protein expression under similar conditions) and high-yield expression of ELP(30UAG)-GFP containing pAzF (~35 mg/L, compared with very low yields generated by progenitor pAcFRS or pAzFRS, that could not be purified) ( Table 1 and Supplementary Fig. 8 ). In addition, we evaluated the production of ELP(30UAG)-GFP in the presence of up to fourfold reduced concentrations of pAcF or pAzF. This analysis revealed that several of our enzyme variants are capable of efficient production of ELP(30UAG)-GFP with 0% or <20% loss in protein yield with twofold or fourfold reduced pAcF concentration (Fig. 4d) , respectively, or with <5% or <30% loss in protein yield with twofold or fourfold reduced pAzF concentration (Fig. 4e) , respectively. Notably, our evolved aaRSs outperformed the progenitor synthetase at all nsAA concentrations. Biochemical in vitro characterization of the aaRS variants was carried out by ATP-PP i exchange and tRNA CUA aminoacylation and confirmed increased activity and respective specificities of our evolved aaRS variants. Although improvement to the k cat /K m of the progenitor enzyme was modest in absolute terms (i.e., ~9 Tables 4 and 5) , the in vivo ELP-GFP suppression efficiency relative to the nsAA supply (Fig. 4d,e) suggested that the nsAA concentration inside the cell was close to the K m . Taken together, these data show that the evolved enzymes with increased pAcF and pAzF incorporation are robust enough to provide sufficient nsAA-tRNA for complete nsAA incorporation. This is likely because the pAcFRS and pAzFRS variants have to supply aa-tRNA to only ~1,500 UAG codons (30 UAG codons on ~50 plasmid copies), whereas TyrRS serves ~40,000 codons in E. coli 42 .
We then evaluated the ability of our plasmid-based orthogonal translation systems to produce ELP(30UAG)-GFP with a panel of 14 nsAAs. A fluorescence assay indicated increased production of ELP(30UAG)-GFP by select aaRS variants for every nsAA in this panel compared with the progenitor pAcFRS (Fig. 4f) , and purification of ELP(30UAG)-GFP containing select nsAAs confirmed high yield (48-65 mg/L, compared with ~65 mg/L for WT protein, Table 1) expression. This analysis also revealed that whereas the pAzFRS.1.t1 maintains stringent specificity for pAzF, the specificity of variant pAcFRS.2.t1 for pAcF over pAzF decreases when expressed on a multicopy plasmid. These results demonstrate that the ELP-GFP fusion protein resolves previously encountered issues of misfolding and aggregation caused by multi-site nsAA incorporation in the GFP open reading frame 20 , while retaining the ability to assay chemically diverse nsAA incorporation by GFP fluorescence. When expressed on multicopy plasmids in the absence of nsAAs, all of our evolved variants showed increased protein production compared with the progenitor enzyme (Fig. 4a-c, gray bars) , which may suggest incorporation of natural amino acids. Accordingly, our plasmid-based, but not the chromosomal-based, variants failed the negative-selection step (Supplementary Fig. 9 ). However, timecourse analysis of GFP(3UAG) or ELP(30UAG)-GFP expression revealed a reduced rate of protein production in the absence of the nsAA (Supplementary Figs. 10 and 11) , and background GFP production was reduced with increasing numbers of UAGs (Fig. 4a-c , gray bars), indicating that incorporation of the nsAA is favored over natural amino acids.
Proteomics analyses confirms accurate nsAA incorporation
We pursued two complementary MS approaches to carefully examine and assay the fidelity of multi-site nsAA incorporation. To quantify the identities of the amino acid at the UAG codons, we used a multiple reaction monitoring (MRM)-based-MS assay 21, 43 . We chose to characterize the most efficient variants (pAcFRS.1.t1 and pAzFRS.2.t1) for production of specially designed reporters, ELP(10UAG)-GFP MS and ELP(30UAG)-GFP MS , and to examine the effect of TAG codon position (i.e., at the N or C terminus) on nsAA incorporation accuracy. Table 6 ), and MRM revealed that the pAc-FRS, pAcFRS.1.t1 and pAzFRS.2.t1 orthogonal translation systems incorporate pAcF at >95% of the peptides for all constructs examined (Fig. 5a,b and Supplementary Note 5) .
Shotgun liquid chromatography (LC)-tandem MS (MS/MS) analysis identified the most prevalent misincorporated amino acids at UAG codons (Supplementary
To examine the effect of UAG codon position with respect to the N terminus, we constructed reporters ELP(10UAG) MS -ELP(20UAG) and ELP(20UAG)-ELP(10UAG) MS (Fig. 5b and Supplementary  Note 2) . We found that N-terminal nsAA incorporation accuracy is independent of UAG codon position and of any local mRNA differences. Analysis of pAzF incorporation accuracy by pAzFRS.1.t1 was also performed with ELP(10UAG)-GFP MS and results were similar to that of pAcF (Supplementary Table 7 and Supplementary Figs. 12  and 13) . We also observed low levels of K, P, S, G, W, L/I and Q with a striking decrease in misincorporation of K, P, L/I and Q content in proteins produced by pAcFRS.1.t1 and pAzFRS.2.t1, but not by pAzFRS.1.t1 (Fig. 5a,b and Supplementary Fig. 13) .
To complement the nsAA quantitation at single sites from MRM, we used LC-MS of intact proteins to obtain quantitative analyses of the ELP(10UAG) and ELP(30UAG) polymers. Using pAcFRS.1.t1 aaRS, we observed that 87% of the ELP(10UAG) proteins had ten (Fig. 5c,d and Supplementary Fig. 14a,b) . These values were used to calculate the single-site accuracy of pAcF incorporation (pure full-length product = (single-site accuracy) n , n equals #UAG codons) and showed 98.6% and 98.9% accuracy for ELP(10UAG) and ELP(30UAG), respectively, which is in quantitative agreement with MRM (97.3% and 98.2%, respectively). Similarly, pAzFRS.2.t1 produced full-length ELP(10UAG) and ELP(30UAG) pure proteins at ratios consistent with MRM analysis ( Supplementary  Fig. 14c,d) .
ELP(30UAG)MS ELP(30UAG)MS ELP(30UAG)MS ELP(20UAG)-ELP(10UAG)MS ELP(10UAG)MS
We then assessed whether our approach affects the robustness of the host organism or host proteins. The fitness of the genomically recoded organism expressing the progenitor and evolved orthogonal translation systems was not impaired due to misincorporation of pAcF or pAzF by native synthetases at non-UAG codons ( Supplementary  Fig. 15) , consistent with our prior findings 21 . Next, we conducted analysis of ELP(10UAG)-GFP MS expressed in the presence of the evolved pAcFRS and pAcF and examined the highly expressed GFPderived peptides FEGDTLVNR and SAMPEGYVQER for pAcF incorporation at F and Y, as they are most structurally similar to pAcF and more likely to mischarge. The results of this analysis revealed only F and Y incorporation, suggesting that pAcF misincorporation is below the level of detection (<0.01%) if it exists at all. We therefore conclude that our system is orthogonal as designed and misincorporation is unlikely to occur at native proteins, which express at levels lower than ELP-GFP. Taken together, these results show that our selected aaRS variants are capable of orthogonal, efficient, multi-site nsAA incorporation in the genomically recoded organism strain along with high protein yields, purity and robust cell fitness.
DISCUSSION
We present an approach for the evolution of aaRS variants capable of multi-site nsAA incorporation in recoded organisms. MAGE has been used to generate combinatorial genomic libraries by targeting multiple and distal genetic loci 29, 30 . Although libraries of chromosomally integrated genes can be generated with other approaches (e.g., recombineering), the low rate of recombination achieved with these methods and limited ability for multi-site combinatorial mutagenesis in vivo result in reduced library complexity 29 . Here, mutagenesis by MAGE enabled simultaneous targeting of an expanded number of residues in the nsAA binding pocket. These libraries facilitated selection of improved aaRSs for a variety of nsAAs-a direct result of the increased number of targeted residues as several of the mutated residues in these variants were not included in previous screens 37, 44 , including a pAzFRS variant (pAzFRS.1) that is both more efficient and more specific for pAzF than previously reported pAzFRSs. Although we do not explore the full diversity of our library in a single evolution (i.e., diversification and selection) experiment (~10 15 for 12 amino acid targets), we were able to perform successive rounds of diversification and selection, without plasmid extraction or transformation steps, by increasing the number of MAGE cycles, changing the mutagenic ssDNA pool, targeting different areas in the aaRS (i.e., the nsAA or tRNA binding site, which can be targeted consecutively or concurrently) or changing the negative-selection conditions (e.g., including pAzF). We expect that the modular nature of our approach will facilitate multiplexed, automated diversification of many aaRS-nsAA pairs, with broad application to other proteins and pathways.
The evolution of a chromosomally integrated protein is an additional advantage of our workflow. Consistent with our original hypothesis, expression of aaRS variants from multi-copy plasmids masked the differences between aaRSs of low, modest and high activity for a protein with only three nsAAs; these differences became evident for a protein with 30 nsAAs (Fig. 4c) or when the aaRS variants were expressed from the chromosome (Fig. 3b-e) . Several of our selected aaRS variants are unique in that they support high levels of protein expression in the absence of an nsAA and death in the presence of the negative-selection marker when expressed from multi-copy plasmids. These observations indicate that our evolved variants would not survive the negative selections conventionally used with plasmid-based orthogonal translation system libraries and therefore could not have been isolated by such approaches. Despite this property, we show high fidelity of nsAA incorporation, which suggests that enhancement of aaRS efficiency may be achieved if aaRS levels are lowered during negative selection such as by reduction of arabinose concentration, reduced strength promoters, or low copy-number plasmids, or if selection stringencies are lowered as previously suggested 39 .
Using the genomically recoded organism and newly evolved aaRS variants, we achieved site-specific multi-site nsAA incorporation with high yields and high purity. Because incorporation accuracy was not biased with respect to position, it should not affect bulk polymer properties. Previous attempts to incorporate more than one instance of an nsAA per protein in strains with no or attenuated RF1 activity showed at best a 33% yield of WT protein when incorporating three instances of an nsAA into superfolder GFP (<20.5 mg/L) 45 and 3% yield of WT when incorporating ten instances of an nsAA into GFP (0.4 mg/L) 20 . Although ELPs are a well-expressed family of proteins 46 , we expect that our approach will improve multi-site nsAA incorporation in a diverse set of natural and recombinant proteins and protein polymers.
In future work, similar orthogonal translation system libraries can be constructed for the Methanosarcina mazei PylRS 28 and the O-phosphoseryl-tRNA 18 synthetase or for co-evolution of multiple orthogonal translation system components (e.g., aaRS, tRNA, EF-Tu) to enable incorporation of chemically diverse, bulky, and highly charged amino acids 5, 18 . In addition, increasing the targeted residue pool (>12 sites), integrated with computational protein design 47 or selection strategies that link cell viability to the incorporation of an nsAAs into essential proteins 48, 49 , will enable strategic targeting and partial randomization of specified residues to increase library coverage.
Multi-site nsAA incorporation will allow control over the chemical and physical properties of protein-based biomaterials. Indeed, limited to only one or a few instances of site-specific nsAA incorporation, most previous work has centered on tag-and-modify approaches or simple protein decorations. Our approach enables site-specific nsAA incorporation where multiple identical nsAAs provide the dominant physical and biophysical properties to biopolymers. As ELPs undergo a sharp soluble-to-insoluble phase transition at their transition temperature, which depends on the ELP composition 46 , ELPs similar to those in this study could be used as a scaffold for smart biomaterials responsive to light, electro-magnetic field and various analytes. Multi-site nsAA incorporation will also allow the design and production of post-translationally modified proteins (e.g., kinases 18 ) for the study and treatment of disease or of new biologics (e.g., antibodies 10 ) with multiple instances of novel chemical functionalities.
As genomically recoded organisms with more free codon channels are constructed 21, 50 , the selection of aaRS variants with tunable or exclusive nsAA specificities enabled by our evolution approach could provide orthogonal coding channels for incorporation of two or more nsAAs within a single protein or sequence-defined polymers.
ONLINE METHODS
See Supplementary Notes 1 and 2 for DNA or protein sequences and Supplementary Notes 5 and 6 for detailed materials and methods for the MRM based-and intact MS.
Assembly of orthogonal translation system integration cassette. To generate an orthogonal translation system integration cassette, previously published 32 p-acetyl-l-phenylalanine aaRS (pAcFRS) gene downstream of the araBAD promoter, a constitutive tRNA CUA under the control of the proK promoter and a tolC expression cassette were amplified using primers containing genomic homology regions or terminal sequence overlaps for Gibson Assembly 51 . The integration cassette was then assembled using Gibson Assembly Master Mix (New England BioLabs) according to the manufacturer's instructions. The orthogonal translation system integration cassette was then amplified by PCR consisting of 2 µl of Gibson Assembly product, 10 pmol each of sense and antisense DNA primers, 50 µl Hot-Start HiFi Mastermix enzyme (Kapa Biosystems) and water for a final volume of 100 µl. The PCR reaction conditions were 95 °C for 2 min for initial denaturation, followed by 30 cycles at 98 °C for 30 s, 65 °C for 30 s and 72 °C for 5 min. The resulting PCR product was visualized on a 1% agarose gel stained with SYBR Safe DNA stain (Invitrogen) and the correct size band was excised and purified using a gel extraction kit (Qiagen). Genomic integration of orthogonal translation system cassette into the genomically recoded organism (E. coli C321.A, CP006698.1, GI:54981157) was performed with 100 ng of the DNA cassette as previously described 52 . Colonies were screened for correct integration by colony PCR and verified by Sanger sequencing. MAGE evolution of orthogonal translation systems. Liquid cell cultures were inoculated from colonies grown at 30 °C to mid-logarithmic growth (optical density at 600 nm of ~0.7) in a shaking incubator. To induce expression of the lambda-red recombination proteins (Exo, Beta and Gam), cell cultures were shifted to 42 °C for 15 min and then immediately chilled on ice. In a 4 °C environment, 1 ml of cells was centrifuged at 16,000g for 30 s. Supernatant medium was removed and cells were resuspended in milli-Q water. The cells were spun down, the supernatant was removed and the cells were washed a second time. After a final 30 s spin, supernatant water was removed and oligos prepared at a concentration of 5-6 µM in DNase-free water were added to the cell pellet. The oligo-cell mixture was transferred to a pre-chilled 1 mm gap electroporation cuvette (Bio-Rad) and electroporated under the following parameters: 1.8 kV, 200 V and 25 mF. Luria-Bertani broth with minimal salts Luria-Bertani broth containing 5 g/L NaCl (LB-min) medium (3 ml) was immediately added to the electroporated cells. The cells were recovered from electroporation and grown at 30 °C for 3-3.5 h. Once cells reached mid-logarithmic growth they were used in additional MAGE cycles, isolated, or assayed for genotype and/or phenotype analysis.
Negative selection. Following the last MAGE cycle, cultures were immediately resuspended in 1ml of LB-min medium containing 0.2% arabinose and colicin E1. After 8 h of incubation at 34 °C, cells were transferred to 3 ml of LB-min medium, grown to an OD 600 of 1.0 in a shaking incubator at 250r.p.m., and frozen in glycerol (20% w/w).
Sequencing of aaRS libraries.
For the MAGE 5 and 9 libraries, we initially established >270 clonal isolates and performed targeted sequencing of the aaRS region to obtain a snapshot of the genetic complexity (Genewiz, Inc.). To further examine the complexity of our library, we conducted high throughput (HT) sequencing of the target region of the nsAA binding site (498 bp, Supplementary Note 4) in libraries created after five and nine MAGE cycles, used for the pAcF and pAzF evolution experiments. To create libraries for HT sequencing, genomic DNA of each of ~2 × 10 9 cells of diversified populations was extracted using a Qiagen Genomic DNA purification kit and 30 cycles of PCR were applied for targeted amplification of the 498 bp region of the mutant aaRS gene. Illumina libraries were prepared by the Yale Center for Genome Analysis (YCGA) with each strain given a unique barcode for pooling. Up to two libraries were pooled for sequencing using Illumina's MiSeq and HiSeq technologies. To capture sequencing information across the entire 498-bp region, 2 × 250 bp paired-end reads were collected for each library. See Supplementary Note 2 for detailed presentation and analysis of sequencing data and estimates of aaRS library complexity.
Plasmid construction. Plasmids bearing GFP-based reporter genes were constructed by insertion of reporter protein genes to a previously described plasmid harboring the gene coding for wild-type GFP, a colE1 origin of replication and a kanamycin resistance marker 21 . The genes encoding for GFP(3UAG) and superfolder GFP were chemically synthesized (IDT), and inserted in place of the existing wild-type GFP gene using the flanking restriction sites EcoRI and HindIII. The gene encoding for ELP(10UAG) or ELP(10Tyr) flanked by BseRI restriction sites, were chemically synthesized (GeneArt, Life Technologies) and inserted sequentially (up to ELP(30UAG) and ELP(30Tyr)) into the BseRI restriction site located at the N terminus of the GFP gene as previously described 53 . A DNA cassette encoding for a leader protein sequence ('MSKGP') was then inserted at the N terminus of the ELP gene to optimize protein expression.
Plasmids bearing the orthogonal translation system components were constructed by insertion of aaRS genes to a previously described plasmid harboring a p15A origin of replication and a chloramphenicol resistance marker 21, 32 . aaRS genes were PCR-amplified from chromosomal templates and inserted sequentially in place of the progenitor pAcFRS gene using the flanking restriction sites BglII and SalI (for copy 1) and NdeI and PstI (for copy 2).
Analysis of GFP expression by intact cell fluorescence measurements.
Liquid cell cultures of strains harboring chromosomally integrated orthogonal translation systems and GFP reporter plasmids were inoculated from frozen stocks and grown to confluence overnight. For plate-based assays, strains harboring orthogonal translation systems and GFP reporter plasmids were inoculated from frozen stocks and grown to confluence overnight. Cultures were then inoculated at 1:20 dilution in LBmin media supplemented with 30 µg/ml kanamycin and allowed to grow at 34 °C to an OD 600 of 0.5-0.8 in a shaking plate incubator at 650 r.p.m. (~3 h). Cultures and inducers were added individually to each well. aaRS expression was then induced by the addition of 0.2% arabinose, GFP expression was induced by the addition of 60 ng/µl anhydrotetracycline, and the appropriate nsAA was added at a concentration of 1 mM. Cells were incubated at 34 °C for an additional 16 h. Liquid cell cultures of strains harboring plasmid-based orthogonal translation systems and GFP or ELP-GFP reporter plasmids were inoculated from frozen stocks and grown to confluence overnight. Cultures were then inoculated at 1:20 dilution in 2× YT media supplemented with 30 µg/ml kanamycin and 20 µg/ml chloramphenicol. Cultures were inoculated by addition of 1:20 confluent cell culture (grown overnight) and aaRS expression was simultaneously induced by the addition of 0.2% arabinose, and the appropriate nsAA was added to a concentration of 1 mM. Cultures and inducers were added individually to each well. Cells were allowed to grow at 34 °C to an OD 600 of 0.5-0.8 in a shaking plate incubator at 650 r.p.m. (~3 h), reporter protein expression was then induced by the addition of 60 ng/µl anhydrotetracycline, and cells were incubated at 34 °C for an additional 16 h.
For 384-well plate-based assays, fluorescence and OD 600 were directly measured following expression. For 96-well plate-based assays, cells were centrifuged at 4,000g for 4 min. Supernatant medium was removed and cells were resuspended in PBS. This process was repeated twice with PBS. GFP fluorescence was measured on a Biotek spectrophotometric plate reader using excitation and emission wavelengths of 395 and 509 nm, respectively). Fluorescence signals were normalized by dividing the fluorescence counts by the OD 600 reading. The nsAAs used in this study were purchased from SigmaAldrich (St. Louis, MO), ChemImpex (Wood Dale, IL), and Bachem (Torrance, CA). Solutions of nsAAs (50 mM) were made in water or 50 mM NaOH; these stock solutions were diluted 50-or 100-fold (to 1 mM final concentration) into medium used for bacterial growth.
Each isolated aaRS was treated as a separate experiment, and GFP levels were compared with the progenitor from which it was evolved by a one-tailed heteroscedastic t-test. Significance is reported where P was found to be <0.01. To verify aaRS activity, we independently re-introduced (by MAGE) the specific identified mutations into the aaRS in the genomically recoded organism
